Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Therapeutic applications for subcutaneous triptans in the acute treatment of migraine.

Authors
  • Erlichson, Kathy
  • Waight, Julie
Type
Published Article
Journal
Current Medical Research and Opinion
Publisher
Informa UK (Librapharm)
Publication Date
Jul 01, 2012
Volume
28
Issue
7
Pages
1231–1238
Identifiers
DOI: 10.1185/03007995.2012.674501
PMID: 22401601
Source
Medline
License
Unknown

Abstract

By virtue of their availability as multiple compounds and in multiple formulations including oral, intranasal, and injectable forms, triptans can be used to customize migraine therapy to the individual patient and the individual migraine attack. Due to its route of delivery and favorable pharmacokinetic profile, subcutaneous triptans may represent an attractive alternative for specific clinical settings. Subcutaneous sumatriptan can play a key role in maximizing likelihood of pain-free response and rapid return to normal daily activities and, as such, should be considered an important part of the treatment armamentarium for migraine.

Report this publication

Statistics

Seen <100 times